Inhaled nanoparticles-An updated review.

Int J Pharm

Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, University of Texas at Austin, Austin, TX 78712, United States. Electronic address:

Published: September 2020

We are providing an update to our previously published review paper on inhaled nanoparticles, thus updating with the most recent reports in the literature. The field of nanotechnology may hold the promise of significant improvements in the health and well-being of patients, as well as in manufacturing technologies. The knowledge of the impact of nanomaterials on public health is limited so far. This paper reviews the unique size-controlled properties of nanomaterials, their disposition in the body after inhalation, and the factors influencing the fate of inhaled nanomaterials. The physiology of the lungs makes it an ideal target organ for non-invasive local and systemic drug delivery, especially for protein and poorly water-soluble drugs that have low oral bioavailability via oral administration. More recently, inhaled nanoparticles have been reported to improve therapeutic efficacies and decrease undesirable side effects via pulmonary delivery. The potential application of pulmonary drug delivery of nanoparticles to the lungs, specifically in context of published results reported on nanomaterials in environmental epidemiology and toxicology is reviewed in this paper. This article presents updated delivery systems, process technologies, and potential of inhaled nanoparticles for local and systemic therapies administered to the lungs. The authors acknowledge the contributions of Wei Yang in our 2008 paper published in this journal.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpharm.2020.119671DOI Listing

Publication Analysis

Top Keywords

inhaled nanoparticles
12
local systemic
8
drug delivery
8
inhaled
5
inhaled nanoparticles-an
4
nanoparticles-an updated
4
updated review
4
review providing
4
providing update
4
update published
4

Similar Publications

Background: Dentists can be exposed to dust and nanoparticles from teeth, dental composites, and metal alloys generated during dental procedures, and exposure to dust can cause respiratory diseases, including pulmonary fibrosis. The authors describe mortality from nonmalignant respiratory diseases (NMRDs) among dentists in the United States.

Methods: The authors submitted information on US dentists who died from 1979 through 2018 to a centralized US death records database to obtain underlying causes of death.

View Article and Find Full Text PDF

Development of a nano-specific safe-by-design module to identify risk management strategies.

Ann Work Expo Health

December 2024

TNO Research Group Risk Analysis for Prevention, Innovation and Development, Princetonlaan 6, PO Box 80015, Utrecht 3584 CB, The Netherlands.

This article describes the development of a Safe-by-Design (SbD) module and its integration into an easy-to-use tool, named the Nano Exposure Quantifier-Safe-by-Design (NEQ-SbD) tool. The NEQ-SbD tool guides its user to lower the exposure to nanomaterials at the worksite where nanomaterials are manipulated or handled during a wide range of activities. This allows the tool user with an informed decision to assess airborne exposure and to select, compare, and identify appropriate risk management measures (RMM).

View Article and Find Full Text PDF

Unlabelled: This assessment was designed to explore and characterize the airborne particles, especially for the sub-micrometer sizes, in an underground coal mine. Airborne particles present in the breathing zone were evaluated by using both (1) direct reading real-time instruments (RTIs) to measure real-time particle number concentrations in the workplaces and (2) gravimetric samplers to collect airborne particles to obtain mass concentrations and conduct further characterizations. Airborne coal mine particles were collected via three samplers: inhalable particle sampler (37 mm cassette with polyvinyl chloride (PVC) filter), respirable dust cyclone (10 mm nylon cyclone with 37 mm Zefon cassette and PVC filter), and a Tsai diffusion sampler (TDS).

View Article and Find Full Text PDF

Redox-activatable inhalable mucoadhesive proteinic nanotherapeutics for targeted treatment of lung cancer.

Biomaterials

May 2025

Department of Chemical Engineering, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea; Medical Science and Engineering, School of Convergence Science and Technology, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea. Electronic address:

Inhalation delivery has been considered a promising choice for treating lung cancer because it can shuttle therapeutic payloads directly to cancer tissues via simple and noninvasive procedures while reducing systemic toxicity. However, its clinical application still faces challenges, especially for delivering hydrophobic chemotherapeutic drugs, due to poor absorption on mucosal tissues and limited therapeutic performance. Herein, we propose inhalable mucoadhesive proteinic nanoparticles (NPs) capable of facilitating reliable pulmonary drug delivery and redox-responsive anticancer therapeutic effects to realize noninvasive, localized treatment of lung cancer in a highly biocompatible, site-specific manner.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!